Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Page logo
Our Company

Johnson & Johnson Statement on Collaboration with Merck
Johnson & Johnson Statement on Collaboration with Merck

New Brunswick, NJ (March 2, 2021) - We are pleased to collaborate with Merck as part of our global network to manufacture our COVID-19 vaccine. Merck has a long history of vaccine expertise, and we expect this manufacturing arrangement will enhance our production capacity so that we can supply beyond our current commitments.

Since January of 2020, we have been working directly with governments, health authorities and other companies to help end this pandemic. Merck is the ninth manufacturer to join our global network and this significant collaboration will further enable us to deliver our COVID-19 vaccine worldwide. We will continue to invest in collaborations so we can bring our full resources and best scientific minds to combat this pandemic.

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue